MarketGrader Ratings Overview
MarketGrader Developed Markets (ex-Australia) Health Care Index
Five Largest Companies (Top 5 of 47)
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 60.7 | $380,574.00 | US |
| UNH | UnitedHealth Group Incorporated | 61.3 | $307,348.00 | US |
| RO.CH | Roche Holding AG | 62.4 | $288,980.47 | CH |
| PFE | Pfizer Inc. | 61.1 | $208,327.00 | US |
| MRK | Merck & Co., Inc. | 69.7 | $197,964.00 | US |
Five Smallest Companies (Top 5 of 3)
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| CHE | Chemed Corporation | 72.9 | $7,747.72 | US |
| NBIX | Neurocrine Biosciences, Inc. | 74.2 | $9,232.24 | US |
| ICLR | ICON Plc | 57.9 | $10,701.10 | IE |
| DVA | DaVita Inc. | 58.0 | $10,943.40 | US |
| REC.IT | Recordati Industria Chimica e Farmaceutica S.p.A. | 65.0 | $11,518.92 | IT |
Companies with Most Selections Among Current Components
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| BIIB | Biogen Inc. | 74.7 | 27 | US |
| NOVO.B.DK | Novo Nordisk A/S Class B | 68.0 | 27 | DK |
| AMGN | Amgen Inc. | 63.6 | 24 | US |
| JNJ | Johnson & Johnson | 60.7 | 19 | US |
| ALXN | Alexion Pharmaceuticals, Inc. | 63.5 | 17 | US |
| RMD | ResMed Inc. | 67.8 | 17 | US |
| LLY | Eli Lilly and Company | 63.2 | 16 | US |
| REGN | Regeneron Pharmaceuticals, Inc. | 76.7 | 15 | US |
| GSK.GB | GlaxoSmithKline plc | 66.8 | 13 | GB |
| HUM | Humana Inc. | 70.4 | 11 | US |
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
| Average Market Cap | $67,097.02 |
| Median Market Cap | $27,177.50 |
| Avg. 3 Mo. Dollar Vol. | $221,493,100.46 |
| Avg. 3 Mo. Trading Vol. | 2,873,353 |
| Last Rebalance Date | 09/21/2020 |
| Companies Replaced | 20 |
| Biggest Industry Increase | Pharmaceuticals: Major |
| Biggest Industry Decrease | Medical Specialties |
Fundamental Attributes
| Trailing P/E Ratio (12 Mo.) | 26.87 |
| Forward P/E Ratio (12 Mo.) | 26.85 |
| Price/Book Ratio | 7.1 |
| Avg. Revenue Chg. - 3 Yr | 28.27% |
| Avg. Op. Income Chg. - 3 Yr. | 70.95% |
| Avg. EPS Growth - 3 Yr. | 21.86% |
| Avg. EPS Growth - 1 Yr. | 18.23% |
| Avg. Operating Margin | 25.27% |
| Avg. LT Debt to Total Capital | 34.17% |
| Avg. Return on Equity | 26.55% |
| Dividend Yield | 0.27% |
Index Average Grade
| MarketGrader Developed Markets (ex-Australia) Health Care Index | 63.48 |
Country Breakdown
| United States Of America | 60.0% |
| Japan | 10.0% |
| Ireland | 6.0% |
| Italy | 4.0% |
| Denmark | 4.0% |
| Korea, Republic Of | 4.0% |
| Switzerland | 4.0% |
| United Kingdom | 2.0% |
| New Zealand | 2.0% |
| France | 2.0% |
| Hong Kong | 2.0% |
For more information on this index please contact us